Ai

© Getty Images

BenevolentAI progresses BEN-34712 for ALS treatment

By Isabel Cameron

BenevolentAI, a clinical-stage AI development company, has announced the successful delivery of its pre-clinical candidate for the potential treatment of amyotrophic lateral sclerosis (ALS), BEN-34712.

Pic:getty/kojofeja

BigHat Biosciences enters AI research collaboration with Merck

By Rachel Arthur

BigHat Biosciences, a US biotech with a machine learning-guided antibody discovery and development platform, has announced a collaboration with Merck to apply its technology to design candidates for up to three drug discovery programs.